<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Sakshi Kolekar on Medium]]></title>
        <description><![CDATA[Stories by Sakshi Kolekar on Medium]]></description>
        <link>https://medium.com/@kolekarsakshi05?source=rss-340886688a5f------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*qQF_hDMqjol9RsBG2okKqw.jpeg</url>
            <title>Stories by Sakshi Kolekar on Medium</title>
            <link>https://medium.com/@kolekarsakshi05?source=rss-340886688a5f------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Tue, 17 Nov 2026 10:07:55 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@kolekarsakshi05/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[PCOS Has a New Name — Here’s What Every Woman Should Know About PMOS]]></title>
            <link>https://medium.com/@kolekarsakshi05/pcos-has-a-new-name-heres-what-every-woman-should-know-about-pmos-3d7429cd9357?source=rss-340886688a5f------2</link>
            <guid isPermaLink="false">https://medium.com/p/3d7429cd9357</guid>
            <category><![CDATA[women-health]]></category>
            <category><![CDATA[pcos-awareness]]></category>
            <category><![CDATA[endocrine-health]]></category>
            <category><![CDATA[reproductive-health]]></category>
            <dc:creator><![CDATA[Sakshi Kolekar]]></dc:creator>
            <pubDate>Fri, 10 Jul 2026 08:23:31 GMT</pubDate>
            <atom:updated>2026-07-10T08:44:00.633Z</atom:updated>
            <content:encoded><![CDATA[<p><strong>PCOS Has a New Name — Here’s What Every Woman Should Know About PMOS</strong></p><p><em>Meta description: In May 2026, The Lancet officially renamed PCOS to PMOS after a 14-year global study. Here’s what changed, what didn’t, and why it matters.</em></p><p>— — — — — — — — — — — — — — —</p><p>If you&#39;ve ever been diagnosed with PCOS, here&#39;s something worth knowing: the condition has a new name. And this isn&#39;t just a label swap — it could reshape how your doctor understands and treats you.</p><p><strong>What Happened</strong></p><p>In May 2026, <em>The Lancet</em> published a landmark global consensus officially renaming <strong>Polycystic Ovary Syndrome (PCOS)</strong> to <strong>Polyendocrine Metabolic Ovarian Syndrome (PMOS)</strong>. The process took 14 years, involved more than 14,300 patients and health professionals across every world region and had backing from 56 academic, clinical and patient organizations — including the Endocrine Society.</p><p><strong>Why &quot;PCOS&quot; Was the Wrong Name All Along</strong></p><p>The word &quot;polycystic&quot; made it sound like ovarian cysts were the core problem. But the science tells a different story:</p><ul><li>Many women with PCOS never develop ovarian cysts at all.</li><li>The condition affects hormones, metabolism, skin, mental health <em>and </em>the reproductive system — not just the ovaries.</li><li>Framing it as a purely gynaecological issue meant metabolic and cardiovascular risks were often overlooked for decades.</li></ul><p><strong>What Stays Exactly the Same</strong></p><ul><li>Your symptoms haven’t changed</li><li>Your existing diagnosis still stands</li><li>Your treatment won’t change overnight</li><li>If you were diagnosed with PCOS, you now have PMOS — same condition, a name that finally fits</li></ul><p><strong>Why This Matters More for Indian Women</strong></p><p>Indian women tend to develop PCOS/PMOS at a lower BMI than women in Western populations, which meant many were missed by diagnostic criteria built around visible cysts or higher weight thresholds. A name and framework centered on metabolic and hormonal markers — not just ovarian appearance — could help doctors catch these cases earlier.</p><p><strong>What You Should Do Now</strong></p><ul><li><strong>Don’t panic</strong> — nothing about your condition has changed, only the name</li><li><strong>Ask about insulin resistance testing</strong>, especially if it hasn’t been done — this is common even in women at a healthy weight</li><li><strong>Ask for a multidisciplinary approach</strong> — not just a gynaecologist, but potentially an endocrinologist and dietitian too</li><li><strong>Keep prioritizing lifestyle changes</strong> — they remain the single most effective long-term treatment</li></ul><p><strong>The Bigger Picture</strong></p><p>PMOS isn&#39;t just a rebrand. It&#39;s medicine catching up with what patients have known for years — that this condition never stayed in one lane. For the 1 in 8 women worldwide affected by it, this shift means a real shot at earlier diagnosis, better coordinated care, and less stigma attached to a name that never told the full story.</p><p>If you&#39;ve been living with PCOS, your journey just got a better map.</p><p>— — — — — — — — — — — — — — —</p><p><em>Sources</em>: <em>Teede HJ, Bahri Khomami M, Morman R, et al. &quot;Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process.” The Lancet, May 12, 2026. Endocrine Society; Yale Medicine.</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*B905aklSitJUYlZT" /><figcaption>Photo by <a href="https://unsplash.com/@kikekiks?utm_source=medium&amp;utm_medium=referral">kike vega</a> on <a href="https://unsplash.com/?utm_source=medium&amp;utm_medium=referral">Unsplash</a></figcaption></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=3d7429cd9357" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[What is Pharmacovigilance and Why Does It Matter?]]></title>
            <link>https://medium.com/@kolekarsakshi05/what-is-pharmacovigilance-and-why-does-it-matter-9e5432f6e549?source=rss-340886688a5f------2</link>
            <guid isPermaLink="false">https://medium.com/p/9e5432f6e549</guid>
            <category><![CDATA[drug-safety]]></category>
            <category><![CDATA[pharmacovigilance]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[pharmacy]]></category>
            <category><![CDATA[adverse-drug-reactions]]></category>
            <dc:creator><![CDATA[Sakshi Kolekar]]></dc:creator>
            <pubDate>Sun, 14 Jun 2026 15:59:36 GMT</pubDate>
            <atom:updated>2026-06-14T16:08:22.893Z</atom:updated>
            <content:encoded><![CDATA[<p><strong>What is Pharmacovigilance and Why Does It Matter?</strong><br><em>Every medicine you’ve ever taken went through a process most people never hear about — here’s what it is.</em><br><strong>The Drug is Approved. The Work Has Just Begun.</strong><br>When a new drug gets approved by regulators, it feels like the finish line. Years of research, clinical trials, and safety reviews — all done. But for pharmacologists and drug safety scientists, approval is actually the starting point of something equally important: <strong><em>Pharmacovigilance</em></strong>.<br><strong>So, What Exactly is Pharmacovigilance?</strong><br>Pharmacovigilance (PV) is the science of detecting, assessing, understanding, and preventing adverse effects — or any other drug-related problems — after a medicine has been released to the public.<br>The World Health Organization (WHO) defines it simply as<em> &quot;the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.&quot;</em><br>In plain terms? It’s how we make sure a drug that seemed safe in clinical trials stays safe — or gets flagged when it doesn’t — once millions of real people start using it.<br><strong>Why Can’t Clinical Trials Catch Everything?</strong><br>This is a fair question. Clinical trials are rigorous, but they have real limitations:<br>• They typically involve <strong>a few hundred to a few thousand</strong> patients<br>• They run for a <strong>fixed time period</strong><br>• They often exclude vulnerable groups like pregnant women, elderly patients, or people with multiple conditions<br>Once a drug reaches the market, it’s used by <strong>millions of people </strong>— across different ages, genetics, lifestyles, and combinations of other medications. That’s when rare or long-term side effects can surface for the first time.<br><strong>Example</strong>: A side effect that occurs in 1 in 10,000 patients might never show up in a trial of 3,000 people — but becomes visible once 10 million people take the drug.<br><strong>How Does Pharmacovigilance Work?</strong><br>The process involves several key activities:<br><strong>1. Adverse Drug Reaction (ADR) Reporting</strong><br>Healthcare professionals, patients, and pharmaceutical companies report unexpected side effects to national regulatory bodies — like the Central Drugs Standard Control Organisation (CDSCO) in India, or the FDA in the US.<br><strong>2. Signal Detection</strong><br>Experts analyze patterns in reported data to identify potential safety &quot;signals&quot; — patterns that suggest a drug may be causing a specific problem.<br><strong>3. Risk Assessment</strong><br>Not every signal is a confirmed risk. Scientists assess whether the drug is truly causing the effect or if other factors are involved.<br><strong>4. Regulatory Action</strong><br>Based on findings, regulators may update a drug’s label, restrict its use, issue safety warnings, or in serious cases — withdraw the drug from the market.<br><strong>A Real-World Example</strong><br>One of the most cited examples in PV history is <strong>Rofecoxib (Vioxx) </strong>— a painkiller withdrawn in 2004 after post-market surveillance revealed it significantly increased the risk of heart attacks and strokes. Clinical trials hadn’t captured this risk at scale. Pharmacovigilance did.<br>Closer to home, India’s Pharmacovigilance Programme of India (PvPI), launched in 2010, has been building a national database of ADR reports to improve drug safety monitoring across the country.<br><strong>Why Should You Care?</strong><br>Whether you’re a patient, a healthcare professional, or simply someone who takes medicines — pharmacovigilance directly affects you.<br>• It’s why drug labels get updated with new warnings<br>• It’s why some medicines are pulled from shelves before they cause more harm<br>• It’s why the medicines available today are safer than those of 30 years ago<br>Every ADR report filed by a doctor or patient contributes to a global safety net that protects millions of people.<br><strong>Final Thought</strong><br>Pharmacovigilance is quiet, unglamorous work — but it’s one of the most important pillars of public health. It’s proof that drug safety isn’t a one-time checkpoint. It’s an ongoing commitment.<br><em>The next time you read about a drug recall or a new warning added to a medication, you’ll know exactly who’s responsible for catching it.</em><br><em>Written by Sakshi | B.Pharm Graduate | Passionate about drug safety and clinical research</em></p><p><strong>Further Reading &amp; References</strong><br>1. World Health Organization — Pharmacovigilance</p><p><a href="https://www.who.int/teams/regulation-prequalification/pharmacovigilance">Pharmacovigilance</a></p><p>2.Pharmacovigilance Programme of India (PvPI)</p><p><a href="https://pvpi.gov.in/">https://pvpi.gov.in</a></p><p>3.FDA MedWatch — Safety Reporting Portal</p><p><a href="https://www.fda.gov/safety/medwatch">MedWatch: FDA Safety Information &amp; Adverse Event Reporting Program</a></p><p>4.Rofecoxib (Vioxx) Withdrawal — A Landmark in Drug Safety</p><p>https://pubmed.ncbi.nlm.nih.gov/15523086</p><figure><img alt="Colorful medication" src="https://cdn-images-1.medium.com/max/1024/0*BF2UCdzXAHewwdSF" /><figcaption>Photo by <a href="https://unsplash.com/@freestocks?utm_source=medium&amp;utm_medium=referral">freestocks</a> on <a href="https://unsplash.com/?utm_source=medium&amp;utm_medium=referral">Unsplash</a></figcaption></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=9e5432f6e549" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>